HomeInsightsShare Holding

Alembic Pharmaceuticals Ltd Share Holding Pattern

Alembic Pharmaceuticals Ltd Share Holding Pattern

stocks purchased

₹ 0.3 Cr

Volume Transacted

(Nov 12, 2024)

stocks purchased

3.2 K

Stocks Traded

(Nov 12, 2024)

Last Updated on: Nov 12, 2024

Promoters Holdings Over Time

Key Highlights

  • Mutual funds increased their stake in the company by 0.23% from March 2024 to June 2024.
  • FIIs/FPIs decreased their stake in the company by 0.14% from March 2024 to June 2024.

Latest Shareholding

Market Price Over Time

1M

1Y

3Y

5Y

Monitoring Alembic Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
12 Nov 20241029.25
11 Nov 20241030.95
08 Nov 20241039
07 Nov 20241081.45
06 Nov 20241139.2
05 Nov 20241126.3
04 Nov 20241124.65
01 Nov 20241121.4
31 Oct 20241128.75
30 Oct 20241083.3

Alembic Pharmaceuticals Ltd News Hub

News

Alembic Pharmaceuticals receives USFDA approval for Ivabradine Tablets

Alembic Pharmaceuticals (Alembic) announced that it has received Final Approval from the U...

Read more

12 Nov 202414:59

News

Alembic Pharmaceuticals receives USFDA approval for Diltiazem Hydrochloride ER capsules

Alembic Pharmaceuticals (Alembic) announced that it has received Final Approval from the U...

Read more

11 Nov 202409:03

News

Alembic Pharma gets US FDA nod for Diltiazem Hydrochloride ER capsules

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD)...

Read more

11 Nov 202409:47

News

Alembic Pharma gets USFDA nod for hypertension treatment drug

The said drug is therapeutically equivalent to the reference listed drug product (RLD), Di...

Read more

21 Oct 202411:23

News

Alembic Pharmaceuticals to discuss results

Alembic Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 7 ...

Read more

18 Oct 202417:20

News

Alembic Pharma's oncology formulations unit successfully completes USFDA inspection

Alembic Pharmaceuticals has successfully completed the United States Food and Drug Adminis...

Read more

09 Oct 202409:16

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

Credit Report 2024

dropdown
download

Concalls

Feb 2023

Transcript

Nov 2022

Transcript

Aug 2022

Transcript

May 2022

Transcript

Nov 2021

Transcript

Aug 2021

Transcript

May 2021

Transcript

FAQs for EPS of Alembic Pharmaceuticals Ltd

On what factors does the shareholding pattern of Alembic Pharmaceuticals Ltd change frequently?

The shareholding pattern of Alembic Pharmaceuticals Ltd can change due to various factors such as stock market transactions, new share issuances, buy-backs, or changes in ownership by institutional and retail investors.

How often is Alembic Pharmaceuticals Ltd's shareholding pattern updated?

The Alembic Pharmaceuticals Ltd shareholding pattern is typically updated quarterly or semi-annually, depending on regulatory requirements and internal reporting schedules.

What categories are included in the shareholding pattern of Alembic Pharmaceuticals Ltd?

Categories included in the shareholding pattern of Alembic Pharmaceuticals Ltd include promoter/management holdings, institutional investors, retail investors, and others such as foreign investors.

Why is the shareholding pattern of Alembic Pharmaceuticals Ltd important for investors?

The shareholding pattern of Alembic Pharmaceuticals Ltd is important for investors as it provides insights into ownership distribution, control dynamics, and the potential influence of major shareholders on company decisions and stock performance.

Where can I find the latest shareholding pattern of Alembic Pharmaceuticals Ltd?

The latest shareholding pattern of Alembic Pharmaceuticals Ltd can be found on BlinkX. You may also check the quarterly financial reports, which are available on the company’s official website under the Investor Relations section. Additionally, you can check stock exchange websites like NSE and BSE for the most recent filings.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*